Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 33 studies | 36% ± 15% | |
| memory B cell | 17 studies | 37% ± 12% | |
| naive B cell | 17 studies | 36% ± 14% | |
| immature B cell | 6 studies | 57% ± 15% | |
| precursor B cell | 5 studies | 52% ± 21% | |
| germinal center B cell | 3 studies | 41% ± 10% |
Insufficient scRNA-seq data for expression of FCRLA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| skin | 72% | 51.21 | 1294 / 1809 | 97% | 143.87 | 459 / 472 |
| lung | 54% | 25.77 | 314 / 578 | 70% | 4.21 | 808 / 1155 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 233.56 | 29 / 29 |
| spleen | 100% | 3419.92 | 241 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 99% | 2599.32 | 917 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 91% | 5.73 | 73 / 80 |
| brain | 47% | 20.72 | 1244 / 2642 | 43% | 2.56 | 304 / 705 |
| stomach | 44% | 29.95 | 159 / 359 | 37% | 4.59 | 106 / 286 |
| intestine | 51% | 481.79 | 494 / 966 | 28% | 2.13 | 149 / 527 |
| tonsil | 0% | 0 | 0 / 0 | 76% | 6.20 | 34 / 45 |
| bladder | 29% | 25.38 | 6 / 21 | 41% | 3.65 | 207 / 504 |
| breast | 24% | 9.98 | 108 / 459 | 38% | 2.11 | 430 / 1118 |
| esophagus | 27% | 18.79 | 397 / 1445 | 27% | 1.25 | 50 / 183 |
| liver | 25% | 7.81 | 57 / 226 | 19% | 1.86 | 78 / 406 |
| pancreas | 2% | 0.44 | 7 / 328 | 42% | 4.63 | 74 / 178 |
| thymus | 17% | 58.20 | 114 / 653 | 26% | 2.39 | 157 / 605 |
| prostate | 25% | 18.54 | 62 / 245 | 18% | 0.66 | 89 / 502 |
| kidney | 25% | 30.57 | 22 / 89 | 14% | 0.45 | 127 / 901 |
| uterus | 4% | 1.05 | 7 / 170 | 30% | 1.23 | 136 / 459 |
| adipose | 23% | 13.00 | 272 / 1204 | 0% | 0 | 0 / 0 |
| heart | 17% | 6.64 | 149 / 861 | 0% | 0 | 0 / 0 |
| muscle | 15% | 15.54 | 117 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 4% | 0.96 | 10 / 258 | 6% | 0.16 | 14 / 230 |
| blood vessel | 10% | 11.04 | 129 / 1335 | 0% | 0 | 0 / 0 |
| ovary | 2% | 0.66 | 3 / 180 | 6% | 0.13 | 26 / 430 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006955 | Biological process | immune response |
| GO_0030154 | Biological process | cell differentiation |
| GO_0007166 | Biological process | cell surface receptor signaling pathway |
| GO_0009897 | Cellular component | external side of plasma membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0004888 | Molecular function | transmembrane signaling receptor activity |
| Gene name | FCRLA |
| Protein name | Fc receptor like A Fc receptor-like A (Fc receptor homolog expressed in B-cells) (Fc receptor-like and mucin-like protein 1) (Fc receptor-like protein) (Fc receptor-related protein X) (FcRX) |
| Synonyms | FCRX UNQ291/PRO329 FREB FCRLM1 FCRL1 FCRL |
| Description | FUNCTION: May be implicated in B-cell differentiation and lymphomagenesis. . |
| Accessions | ENST00000674251.1 [Q7L513-14] ENST00000367953.7 [Q7L513-2] ENST00000674323.1 [Q7L513-9] Q5VXA5 ENST00000294796.8 [Q7L513-4] ENST00000367950.2 ENST00000309691.10 [Q7L513-3] ENST00000540521.5 [Q7L513-11] Q7L513 ENST00000546024.5 [Q7L513-12] ENST00000349527.8 [Q7L513-8] ENST00000350710.3 [Q7L513-15] ENST00000367959.6 [Q7L513-10] ENST00000236938.12 [Q7L513-1] ENST00000367949.6 [Q7L513-13] ENST00000367957.7 [Q7L513-5] |
